Comparison of loss of response between anti-tumor necrosis factor alone and combined use with immunomodulators in patients with inflammatory bowel disease.

Conclusions: Anti-TNF and IMM combination therapy did not prove efficacious in preventing the development of LOR in IBD patients. Female sex was associated with the development of LOR to anti-TNF; further studies are required to confirm these results.
PMID: 32580540 [PubMed - as supplied by publisher]

Source: Methods of Information in Medicine - June 24, 2020 Category: Information Technology Authors: Hong SW, Park J, Yoon H, Yang HR, Shin CM, Park YS, Kim N, Lee DH, Kim JS Tags: Korean J Intern Med Source Type: research